American voters have a simple health care message for 2020: just fix it!

2 June 2019 - In surveys, many voters say they’re open to solutions, regardless of the political party proposing them. ...

Read more →

Physicians’ perspectives on FDA approval standards and off-label drug marketing

22 January 2019 - Recently, two fundamental aspects of the US FDA’s pharmaceutical market oversight have become controversial.  ...

Read more →

2019 oncology drugs in pipeline — survey

14 December 2018 - pCODR is again undertaking its periodic survey to facilitate consistent and systematic data collection from participating ...

Read more →

Differentiation of health-related quality of life outcomes between five disease areas: results from an international survey of patients

25 September 2018 - Health-related quality of life data generated by generic, preference-based instruments are highly demanded in health policy decision ...

Read more →

Majority think Trump's drug plan won't lower prices they pay

23 July 2018 - A majority of the public thinks that President Trump’s drug-pricing plan will have no impact on ...

Read more →

Deloitte survey finds biopharma companies are accelerating adoption of real-world evidence

28 June 2018 - A recent survey shows that 90% of biopharma companies are making significant investments in real-world evidence ...

Read more →

Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience

31 May 2018 - Innovative pricing agreements for medicines have been used in European markets for more than 20 years, ...

Read more →

Is “end of life” a special case? Connecting Q with survey methods to measure societal support for views on the value of life-extending treatments

19 January 2018 - Preference elicitation studies reporting societal views on the relative value of end-of-life treatments have produced equivocal results.  ...

Read more →

EMA surveys pharma companies on their preparedness for Brexit

23 January 2018 - Planning of regulatory steps needed to ensure medicines remain on EU market. ...

Read more →

Costly drugs to weigh on U.S. employers' expenses in 2018: survey

18 September 2017 - U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs ...

Read more →

EMA launches second communication perception survey

11 May 2017 - The EMA has launched its bi-annual communication perception surveyExternal link icon. ...

Read more →

Survey shows biotech industry buoyant, but fearing imminent policy change

2 May 2017 - AusBiotech’s annual survey of biotechnology industry CEOs shows the strongest year on record, but the result ...

Read more →

Majorities of Democrats, Republicans and Independents support actions to lower drug costs, including allowing Americans to buy drugs from Canada

1 May 2017 - Most say importing Canadian drugs would lower costs without affecting quality, though some have concerns about unsafe ...

Read more →

Payers’ experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia

1 April 2017 - Institutional payers for pharmaceuticals worldwide appear to be increasingly negotiating confidential discounts off of the official list ...

Read more →

AusPAR user survey results

23 November 2016 - The survey was to help the TGA identify the audience for AusPARs, understand what AusPARs were being ...

Read more →